| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
B. R. Cassileth, The alternative medicine handbook
|
F. Jungi
|
|
1998
|
9 |
6 |
p. 682-682
1 p.
|
article
|
| 2 |
Colorectal cancer screening: Health policy or a continuing researchissue?
|
P. Boyle
|
|
1998
|
9 |
6 |
p. 581-584
4 p.
|
article
|
| 3 |
Control of delayed nausea and vomiting with granisetron plusdexamethasone or dexamethasone alone in patients receiving highly emetogenicchemotherapy: A double-blind, placebo-controlled, comparative study
|
L. Goedhals
|
|
1998
|
9 |
6 |
p. 661-666
6 p.
|
article
|
| 4 |
Effective treatment of advanced biliary tract carcinoma using5-fluorouracil continuous infusion with cisplatin
|
M. Ducreux
|
|
1998
|
9 |
6 |
p. 653-656
4 p.
|
article
|
| 5 |
Five-year follow-up of a prospective randomised multi-centre trial ofweekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in thetreatment of aggressive non-Hodgkins lymphoma
|
N. P. Bailey
|
|
1998
|
9 |
6 |
p. 633-638
6 p.
|
article
|
| 6 |
From the R.E.A.L. Classification to the upcoming WHO scheme: A steptoward universal categorization of lymphoma entities?
|
S. A. Pileri
|
|
1998
|
9 |
6 |
p. 607-612
6 p.
|
article
|
| 7 |
Has Hodgkins disease finally been conquered, in the bicentennial yearof its describers birth?; Germany to follow Switzerland in distributingheroin?; Should silicone implants be banned in Europe?; Australian CancerSociety names new Chief Executive Officer; Are American cancer data raciallybiased?; Perhaps not everyone knows that...
|
|
|
1998
|
9 |
6 |
p. 575-579
5 p.
|
article
|
| 8 |
Hereditary persistence of -fetoprotein
|
H. Schefer
|
|
1998
|
9 |
6 |
p. 667-672
6 p.
|
article
|
| 9 |
Hodgkins disease occurring in a child after liver transplantation
|
V. Conter
|
|
1998
|
9 |
6 |
p. 673-676
4 p.
|
article
|
| 10 |
Induction chemotherapy, surgery, and concomitant chemoradiotherapy forcarcinoma of the esophagus: A long-term analysis
|
P. C. Hoffman
|
|
1998
|
9 |
6 |
p. 647-651
5 p.
|
article
|
| 11 |
Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women withadvanced breast cancer
|
M. Gershanovich
|
|
1998
|
9 |
6 |
p. 639-645
7 p.
|
article
|
| 12 |
Malignant glioma: Should chemotherapy be overthrown by experimentaltreatments?
|
P. Hösli,
|
|
1998
|
9 |
6 |
p. 589-600
12 p.
|
article
|
| 13 |
P. R. Algra, J. Valk, J. J. Heimans (eds), Diagnosis and therapy ofspinal tumors
|
D. May
|
|
1998
|
9 |
6 |
p. 580-580
1 p.
|
article
|
| 14 |
Prevention of colorectal cancer: A cost-effectiveness approach to ascreening model employing sigmoidoscopy
|
J. Norum
|
|
1998
|
9 |
6 |
p. 613-618
6 p.
|
article
|
| 15 |
The ESMO programme of certification and training for medicaloncology
|
D. J. Th. Wagener
|
|
1998
|
9 |
6 |
p. 585-587
3 p.
|
article
|
| 16 |
The pitfalls of narrative reviews in clinical medicine
|
C. J. Williams
|
|
1998
|
9 |
6 |
p. 601-605
5 p.
|
article
|
| 17 |
Veno-occlusive disease of the liver induced by gemcitabine
|
M. Dobbie
|
|
1998
|
9 |
6 |
p. 681-681
1 p.
|
article
|
Journal description